Could Stroke Drug Tissue Plasminogen Activator (tPA) Help Treat COVID-19 Patients?

By Serena Gordon
HealthDay Reporter

FRIDAY, March 27, 2020 — For people today extremely unwell with COVID-19, obtain to a mechanical ventilator can mean daily life or death. Difficulties is, they’re in quick supply in the United Sates and close to the earth.

Now, study suggests that a widely used clot-busting stroke drug could possibly aid COVID-19 clients who won’t be able to obtain a ventilator or who fall short to improve even when they do gain obtain.

The study focuses on a drug termed tissue plasminogen activator (tPA), which is ordinarily used to quickly dissolve blood clots that bring about strokes or coronary heart attacks.

New info from China and Italy counsel that people today with COVID-19 have a major blood-clotting condition. People in respiratory failure produce blood clots in the lungs and little blockages in the lung’s blood vessels. These little clots preserve blood from achieving air spaces

Read More